Glaukos Corp (GKOS): Total Liabilities
$237.33M
As of 2025-12-31
$238.03M
As of 2026-06-30
-20.5%
3-year compound annual growth
-6.8%
5-year compound annual growth
+27.2%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $237.33M | +14.2% | 2026-02-23, Balance as of period end |
| 2024-12-31 | $207.82M | -56.6% | 2026-02-23, Balance as of period end |
| 2023-12-31 | $478.65M | +1.3% | 2025-02-25, Balance as of period end |
| 2022-12-31 | $472.38M | +2.1% | 2024-02-23, Balance as of period end |
| 2021-12-31 | $462.55M | +36.8% | 2023-02-24, Balance as of period end |
| 2020-12-31 | $338.05M | +132.9% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $145.13M | +338.3% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $33.11M | +19.8% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $27.63M | +61.6% | 2019-02-28, Balance as of period end |
| 2016-12-31 | $17.10M | -20.4% | 2018-02-28, Balance as of period end |
| 2015-12-31 | $21.47M | -27.3% | 2017-03-15, Balance as of period end |
| 2014-12-31 | $29.55M | n/a | 2016-03-15, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Glaukos Corp (GKOS) | 2025-12-31 | $237.33M | +14.2% |
| AtriCure, Inc. (ATRC) | 2025-12-31 | $162.24M | +9.4% |
| Bioventus Inc. (BVS) | 2025-12-31 | $455.11M | -16.1% |
| Artivion, Inc. (AORT) | 2025-12-31 | $436.56M | -14.9% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $231.20M | -19.2% |
| Mimedx Group, Inc. (MDXG) | 2025-12-31 | $86.11M | +21.6% |
| Accuray Inc (ARAY) | 2026-06-30 | $401.98M | +3.3% |
| NovoCure Ltd (NVCR) | 2025-12-31 | $463.86M | -47.3% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $867.30M | +3.2% |
Compare GKOS, ATRC, BVS, AORT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗